Other

Payments to Acquire Intangible Assets

ResMed Payments to Acquire Intangible Assets increased by 100.0% to $0.00 in Q1 2026 compared to the prior quarter. Over 4 years (FY 2021 to FY 2025), Payments to Acquire Intangible Assets shows a downward trend with a -6.5% CAGR.

Analysis

StatementIncome Statement
SectionOther
CategoryCapital Allocation
SignalContext dependent
VolatilityModerate
First reportedQ1 2024
Last reportedQ1 2026

How to read this metric

High spending suggests a focus on innovation and strengthening intellectual property, which is vital for tech-heavy companies.

Detailed definition

Represents cash outflows for the acquisition of non-physical assets such as patents, software licenses, or brand rights....

Peer comparison

Common in technology and pharmaceutical sectors where IP is a primary driver of value.

Metric ID: other_payments_to_acquire_intangible_assets

Historical Data

20 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value$2.97M$4.45M$9.28M$3.71M$3.75M$3.32M$4.32M$2.41M$4.29M$10.83M$1.21M$1.92M$1.44M$1.77M-$1.77M$0.00$10.78M$2.81M-$1.34M$0.00
QoQ Change+50.2%+108.5%-60.0%+1.1%-11.6%+30.2%-44.3%+78.0%+152.8%-88.9%+59.2%-24.8%+22.5%-200.0%+100.0%-73.9%-147.4%+100.0%
YoY Change+26.5%-25.5%-53.5%-35.2%+14.2%+226.5%-72.1%-20.3%-66.3%-83.7%-246.6%-100.0%+647.4%+59.3%+24.4%
Range-$1.77M$10.83M
CAGR-100.0%
Avg YoY Growth+19.7%
Median YoY Growth-25.5%

Frequently Asked Questions

What is ResMed's payments to acquire intangible assets?
ResMed (RMD) reported payments to acquire intangible assets of $0.00 in Q1 2026.
What is the long-term trend for ResMed's payments to acquire intangible assets?
Over 4 years (2021 to 2025), ResMed's payments to acquire intangible assets has grown at a -6.5% compound annual growth rate (CAGR), from $14.11M to $10.78M.
What does payments to acquire intangible assets mean?
Cash spent on acquiring non-physical assets like patents or software.